Analyst · Jazz Pharmaceuticals plc (JAZZ) | Ratings, Price Targets & Consensus

Analyst Consensus

Buy40 analysts

Buy

Updated Aug 6, 2026

Total Analysts40

Buy

43

Hold

5

Ratings

Updated Aug 6, 2026

Overall Rating

A-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score3.0 / 5

ROA Score4.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$256.65

Median Target-4.13%

$246.05

Potential downside vs current price

DCF Value+64.49%

$422.17

Potential upside vs current price

Current Stock Price

$256.65

Median Target-4.13%

$246.05

Potential downside vs current price

DCF Value+64.49%

$422.17

Potential upside vs current price

Analyst Consensus

Buy40 analysts

Buy

Updated Aug 6, 2026

Total Analysts40

Buy

43

Hold

5

Ratings

Updated Aug 6, 2026

Overall Rating

A-

DCF Score5.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score3.0 / 5

ROA Score4.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$256.65

Median Target-4.13%

$246.05

Potential downside vs current price

DCF Value+64.49%

$422.17

Potential upside vs current price

Current Stock Price

$256.65

Median Target-4.13%

$246.05

Potential downside vs current price

DCF Value+64.49%

$422.17

Potential upside vs current price